Extensor digitorum brevis test and resistance to botulinum toxin type A
暂无分享,去创建一个
[1] S Fahn,et al. Development of resistance to botulinum toxin type A in patients with torticollis , 2004, Movement disorders : official journal of the Movement Disorder Society.
[2] R. Richard Sloop,et al. Muscle paralysis produced by botulinum toxin type A injection in treated torticollis patients compared with toxin naive individuals , 2001, Movement disorders : official journal of the Movement Disorder Society.
[3] J. Rothwell,et al. The sternocleidomastoid test: an in vivo assay to investigate botulinum toxin antibody formation in humans , 2000, Journal of Neurology.
[4] A. Lees,et al. Further studies using higher doses of botulinum toxin type F for torticollis resistant to botulinum toxin type A , 1998, Journal of neurology, neurosurgery, and psychiatry.
[5] K. Wohlfarth,et al. Botulinum A Toxin Therapy: Neutralizing and Nonneutralizing Antibodies—Therapeutic Consequences , 1997, Experimental Neurology.
[6] R. Sloop,et al. Human response to botulinum toxin injection: Type B compared with type A , 1997, Neurology.
[7] R. Sloop,et al. Reconstituted Botulinum Toxin Type A Does Not Lose Potency in Humans If It Is Refrozen or Refrigerated for 2 Weeks Before Use , 1997, Neurology.
[8] R. Benecke,et al. The EDB Test—A clinical test for the detection of antibodies to botulinum toxin type A , 1997 .
[9] G. Peterson,et al. Dose‐response curve of human extensor digitorum brevis muscle function to intramuscularly injected botulinum toxin type A , 1996, Neurology.
[10] K. Schwartz,et al. Response and immunoresistance to botulinum toxin injections , 1995, Neurology.
[11] F. Walker,et al. Serial neurophysiological studies of intramuscular botulinum‐A toxin in humans , 1994, Muscle & nerve.
[12] C. Hatheway,et al. Immunogenicity of the neurotoxins of Clostridium botulinum , 1994 .
[13] N. Bathien,et al. Botulinum antibodies in dystonic patients treated with type A botulinum toxin , 1993, Neurology.
[14] H E Cohen,et al. Antitoxins and botulinum toxin treatment. , 1992, BMJ.
[15] J. Jankovic,et al. Therapeutic uses of botulinum toxin. , 1991, The New England journal of medicine.
[16] E. Schantz,et al. Dose standardisation of botulinum toxin , 1990, The Lancet.
[17] L. S. Siegel,et al. Human immune response to botulinum pentavalent (ABCDE) toxoid determined by a neutralization test and by an enzyme-linked immunosorbent assay , 1988, Journal of clinical microbiology.
[18] D. Lison,et al. Dose standardization of botulinum toxin. , 1998, Advances in neurology.
[19] S. Fahn,et al. Use of botulinum toxin type F injections to treat torticollis in patients with immunity to botulinum toxin type A , 1993, Movement disorders : official journal of the Movement Disorder Society.
[20] D. Kautter,et al. Standardized assay for Clostridium botulinum toxins [in foods]. , 1978 .